U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07722299) titled 'A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAL0167 in Healthy Participants' on July 17.
Brief Summary: This study aims to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of SAL0167 following single and multiple dose administration in healthy participants. The study consists of two parts (Part A and Part B) with 120 participants planned to be enrolled. Possible adjustments to sample size, treatment duration will depend upon emerging data.
Study Start Date: July 21
Study Type: INTERVENTIONAL
Condition:
Hyperlipidemia
Intervention:
DRUG: SAL0167 group
Drug: SAL0...